![Andreas Emmenegger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Emmenegger
Directeur/Membre du Conseil chez
LUZERNER KANTONALBANK AG
Profil
Andreas Emmenegger was the founder of PIQUR Therapeutics AG, founded in 2011, and served as Member-Supervisory Board from 2011 to 2018.
Mr. Emmenegger is also the founder of Targimmune Therapeutics AG.
Current positions include Member-Supervisory Board at Luzerner Kantonalbank AG since 2016, Member-Management Board at Molecular Partners, Inc., Chief Financial Officer at Owkin Switzerland SARL, and Chief Financial & Business Officer at Swiss Rockets AG.
Former positions include Head-Strategic Alliance Finance at F.
Hoffmann-La Roche Ltd. from 2006 to 2007, Chief Financial Officer at Interroll Holding AG from 1997 to 2000, Chief Financial Officer at The Fantastic Co. AG from 2000 to 2003, Chief Financial Officer at Roche Glycart AG from 2005 to 2006, Chief Financial Officer at Molecular Partners AG from 2006 to 2022, Controller at Dräger Beteiligungen AG from 1992 to 1996, and Principal at Roche Holding AG.
Education includes undergraduate studies at Lucerne University of Applied Sciences & Arts and undergraduate and MBA degrees at Instituto de Estudios Superiores de la Empresa.
Postes actifs de Andreas Emmenegger
| Sociétés | Poste | Début |
|---|---|---|
| LUZERNER KANTONALBANK AG | Directeur/Membre du Conseil | 01/01/2016 |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Fondateur | - |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | - |
Swiss Rockets AG
 Swiss Rockets AG BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries provides drug development services | Directeur Financier/CFO | - |
Anciens postes connus de Andreas Emmenegger
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR PARTNERS AG | Directeur Financier/CFO | 31/12/2022 |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: MajorHealth Technology Engages in discovery and development of anti-cancer drugs | Fondateur | 01/04/2018 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2007 |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products | Directeur Financier/CFO | 01/01/2006 |
| THE FANTASTIC COMPANY AG | Directeur Financier/CFO | 01/01/2003 |
Formation de Andreas Emmenegger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Luzerner Kantonalbank AG
 Luzerner Kantonalbank AG Regional BanksFinance Engages in banking services | Finance |
Interroll Holding AG
 Interroll Holding AG Industrial MachineryProducer Manufacturing Manufactures conveyors and sorters products | Producer Manufacturing |
The Fantastic Co. AG
 The Fantastic Co. AG Financial ConglomeratesFinance Invests in private equity management companies | Finance |
Roche Glycart AG
Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products | Health Technology |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Dräger Beteiligungen AG | |
Lucerne University of Applied Sciences & Arts
 Lucerne University of Applied Sciences & Arts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto de Estudios Superiores de la Empresa
 Instituto de Estudios Superiores de la Empresa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: MajorHealth Technology Engages in discovery and development of anti-cancer drugs | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Health Technology |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Swiss Rockets AG
Swiss Rockets AG BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries provides drug development services | Health Technology |
